secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0000950170-25-081604
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences closes $4M public offering of common stock and warrants
------------------------------------------------------------------------------

- Gross proceeds ~$4M from sale of 3,640,000 shares (or pre-funded warrants) plus warrants for up to 14,560,000 shares.
- Warrants exercise price $1.10/share, exercisable after stockholder approval, expire 5 years from initial exercise date.
- Net proceeds to fund Phase 1b study, clinical drug supply manufacture, preclinical work, and general corporate purposes.
- Roth Capital Partners acted as sole placement agent; offering closed May 29, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025081604/0000950170-25-081604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025081604/revb-20250528.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-081604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer